AirSculpt Technologies' P/S ratio aligns with the Healthcare industry despite promising revenue growth. Their share price suggests investor uncertainty about reaching future growth targets.
The last year of insider transactions indicate a positive outlook for AirSculpt Technologies, despite its recent stock price dip. The considerable insider ownership might suggest the management and shareholders are well-aligned, hinting at a promising stock performance.
Airsculpt Technologies股票討論區
Watching
$Carvana(CVNA.US)$$Allogene Therapeutics(ALLO.US)$$Upstart(UPST.US)$$Airsculpt Technologies(AIRS.US)$$Marathon Digital(MARA.US)$
Expecting a rug pull
Such a great stock
30% up so far 🥹
暫無評論